OrbiMed’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-551,500
Closed -$12.4M 139
2016
Q4
$12.4M Buy
551,500
+180,600
+49% +$4.05M 0.16% 81
2016
Q3
$8.42M Hold
370,900
0.1% 102
2016
Q2
$8.75M Sell
370,900
-467,200
-56% -$11M 0.09% 95
2016
Q1
$17.1M Sell
838,100
-463,600
-36% -$9.46M 0.18% 66
2015
Q4
$67M Buy
1,301,700
+317,000
+32% +$16.3M 0.61% 46
2015
Q3
$42M Buy
984,700
+134,000
+16% +$5.71M 0.42% 48
2015
Q2
$38.7M Hold
850,700
0.32% 61
2015
Q1
$32.3M Hold
850,700
0.28% 62
2014
Q4
$24.1M Hold
850,700
0.23% 65
2014
Q3
$21.5M Sell
850,700
-510,900
-38% -$12.9M 0.22% 68
2014
Q2
$39.7M Buy
1,361,600
+403,900
+42% +$11.8M 0.47% 47
2014
Q1
$24.8M Hold
957,700
0.31% 55
2013
Q4
$24.7M Buy
957,700
+630,700
+193% +$16.2M 0.36% 55
2013
Q3
$8.75M Sell
327,000
-153,319
-32% -$4.1M 0.16% 72
2013
Q2
$11.8M Buy
+480,319
New +$11.8M 0.25% 63